CC
BCAX

Caxton Corporation’s Bicara Therapeutics Inc. Common Stock BCAX Stock Holding History

Caxton Corporation’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$102K Hold
10,941
– – 1.03% 7
2025
Q1 		$143K Hold
10,941
– – 2.81% 5
2024
Q4 		$191K Hold
10,941
– – 1.15% 7
2024
Q3 		$279K Buy
+10,941
New +$279K 1.15% 5